First-in-man Study of Single and Multiple Ascending Doses of a New Drug for Neurological Disorders

Summary

The primary purpose of this first-in-man study is to investigate whether a new drug for neurological disorders is safe and well-tolerated when administered orally to healthy adults

Timeline

Start

2016-02-01

Primary completion

2017-03-06

Completion

2017-03-06

Drugs

Indications

No indication recorded.